Search Results - "Vonderheid, E C"

Refine Results
  1. 1

    Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma by Bisaccia, E., Vonderheid, E.C., Geskin, L.

    Published in British journal of dermatology (1951) (01-07-2009)
    “…Summary Background  Extracorporeal photopheresis (ECP) is an approved palliative treatment for cutaneous T‐cell lymphoma (CTCL). The THERAKOS™ CELLEX™…”
    Get full text
    Journal Article
  2. 2
  3. 3

    BCL2 and JUNB abnormalities in primary cutaneous lymphomas by Mao, X., Orchard, G., Lillington, D.M., Child, F.J., Vonderheid, E.C., Nowell, P.C., Bagot, M., Bensussan, A., Russell-Jones, R., Young, B.D., Whittaker, S.J.

    Published in British journal of dermatology (1951) (01-09-2004)
    “…Summary Background  BCL2 is upregulated in nodal and extranodal B‐cell non‐Hodgkin's lymphomas, with a consequent antiapoptotic effect. However, loss of BCL2…”
    Get full text
    Journal Article
  4. 4

    Interleukin-12 Therapy of Cutaneous T-Cell Lymphoma Induces Lesion Regression and Cytotoxic T-Cell Responses by Rook, Alain H., Wood, Gary S., Yoo, Elisa K., Elenitsas, Rosalie, Kao, David M.F., Sherman, Matthew L., Witmer, William K., Rockwell, Kenneth A., Shane, Ryan B., Lessin, Stuart R., Vonderheid, Eric C.

    Published in Blood (01-08-1999)
    “…Progression of cutaneous T-cell lymphoma (CTCL) is associated with profound defects in cell-mediated immunity and depressed production of cytokines, which…”
    Get full text
    Journal Article
  5. 5

    Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis by Cowen, E.W., Liu, C-W., Steinberg, S.M., Kang, S., Vonderheid, E.C., Kwak, H.S., Booher, S., Petricoin, E.F., Liotta, L.A., Whiteley, G., Hwang, S.T.

    Published in British journal of dermatology (1951) (01-11-2007)
    “…Summary Background  Serum proteomic analysis is an analytical technique utilizing high‐throughput mass spectrometry (MS) in order to assay thousands of serum…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma by Vonderheid, Eric C., Zhang, Qian, Lessin, Stuart R., Polansky, Marcia, Abrams, J.Todd, Bigler, Robert D., Wasik, Mariusz A.

    “…Background: The serum concentration of soluble a chain of the interleukin-2 receptor (sIL-2R) correlates with tumor burden in cutaneous T-cell lymphoma (CTCL)…”
    Get full text
    Journal Article
  8. 8

    Radiotherapy for unilesional mycosis fungoides by Micaily, B, Miyamoto, C, Kantor, G, Lessin, S, Rook, A, Brady, L, Goodman, R, Vonderheid, E C

    “…To evaluate the treatment outcome and natural history of patients with the diagnosis of unilesional mycosis fungoides, treated according to a prospective…”
    Get more information
    Journal Article
  9. 9

    Genetic markers associated with progression in early mycosis fungoides by Johnson, V.E., Vonderheid, E.C., Hess, A.D., Eischen, C.M., McGirt, L.Y.

    “…Background Mycosis fungoides (MF) is a rare, but potentially devastating malignancy. It classically presents with cutaneous patches and plaques and can…”
    Get full text
    Journal Article
  10. 10

    Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing by Nagasawa, T., Zhang, Q., Raghunath, P.N., Wong, H.Y., El-Salem, M., Szallasi, A., Marzec, M., Gimotty, P., Rook, A.H., Vonderheid, E.C., Odum, N., Wasik, M.A.

    Published in Leukemia research (01-03-2006)
    “…To understand better T-cell lymphomagenesis, we examined promoter CpG methylation and mRNA expression of closely related genes encoding p16, p15, and p14 tumor…”
    Get full text
    Journal Article
  11. 11

    Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 Cells by Vowels, Benjamin R, Cassin, Maureen, Vonderheid, Eric C, Rook, Alain H

    Published in Journal of investigative dermatology (01-07-1992)
    “…Sezary syndrome (SzS), the leukemic stage of cutaneous T-cell lymphoma (CTCL), is typically a CD4+ T-cell lympho-proliferative disease characterized by…”
    Get full text
    Journal Article
  12. 12

    Cutaneous T-cell lymphoma in association with silicone breast implants by Duvic, Madeleine, Moore, Dennis, Menter, Alan, Vonderheid, Eric C

    “…Background: Cutaneous T-cell lymphoma (CTCL) is a chronic malignancy of helper T cells with the CD4 phenotype. It occurs less frequently in young women but is…”
    Get full text
    Journal Article
  13. 13

    p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: A study of 12 cases by Marrogi, A. J., Khan, M. A., Vonderheid, E. C., Wood, G. S., McBurney, E.

    Published in Journal of cutaneous pathology (01-09-1999)
    “…The transformation of cutaneous T‐cell lymphoma (t‐CTCL) is an uncommon phenomenon that is associated with histopathologic changes and follows an aggressive…”
    Get full text
    Journal Article
  14. 14

    Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) by Galindo, L M, Garcia, F U, Hanau, C A, Lessin, S R, Jhala, N, Bigler, R D, Vonderheid, E C

    Published in American journal of clinical pathology (01-06-2000)
    “…We studied the role of fine-needle aspiration (FNA) in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (CTCL) in 11 patients with…”
    Get full text
    Journal Article
  15. 15

    Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes by Agnarsson, B A, Vonderheid, E C, Kadin, M E

    “…We identified nine patients with cutaneous T cell lymphoma in whom the neoplastic cells expressed the CD8 (T8) suppressor T cell phenotype instead of the more…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Sarcoidal tissue reaction in Sézary syndrome by Gregg, Patrick J., Kantor, Gary R., Telang, Gladys Hines, Lessin, Stuart R., Nowell, Peter C., Vonderheid, Eric C.

    “…Sézary syndrome (SS) is an erythrodermic and leukemic variant of cutaneous T-cell lymphoma (CTCL). Occasionally, the histology of CTCL exhibits evidence of a…”
    Get full text
    Journal Article
  18. 18

    Autologous bone marrow transplantation for advanced stage mycosis fungoides by Bigler, R D, Crilley, P, Micaily, B, Brady, L W, Topolsky, D, Bulova, S, Vonderheid, E C, Brodsky, I

    Published in Bone marrow transplantation (Basingstoke) (01-02-1991)
    “…Patients with advanced stage cutaneous T cell lymphoma (CTCL) have a median survival of 2-5 years with no currently available curative therapy. This limited…”
    Get more information
    Journal Article
  19. 19

    Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma by Kari, Laszlo, Loboda, Andrey, Nebozhyn, Michael, Rook, Alain H, Vonderheid, Eric C, Nichols, Calen, Virok, Dezso, Chang, Celia, Horng, Wen-Hwai, Johnston, James, Wysocka, Maria, Showe, Michael K, Showe, Louise C

    Published in The Journal of experimental medicine (02-06-2003)
    “…We have used cDNA arrays to investigate gene expression patterns in peripheral blood mononuclear cells from patients with leukemic forms of cutaneous T cell…”
    Get full text
    Journal Article
  20. 20

    Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma by Vonderheid, E C, Tan, E T, Kantor, A F, Shrager, L, Micaily, B, Van Scott, E J

    “…Complete responses lasting from 4 to 14 years were documented in 65 of 331 (20%) patients with cutaneous T cell lymphoma treated with topical mechlorethamine…”
    Get more information
    Journal Article